LGND short interest
Ligand Pharmaceuticals Incorporated · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 2,677,998 |
|---|---|
| Change vs prior report | 45,564 (+1.7%) |
| Change over six months | +79.1% |
| Days to cover | 8.73 (sector: 3.78) |
| Average daily volume | 306,650 |
| Rank in Healthcare | #166 of 922 by days to cover |
LGND short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,677,998 | +1.7% | 8.73 | 306,650 |
| 2026-09-15 | 2,632,434 | +6.1% | 13.53 | 194,509 |
| 2026-08-31 | 2,480,981 | +1.3% | 14.12 | 175,764 |
| 2026-08-14 | 2,448,076 | +12.8% | 8.76 | 279,423 |
| 2026-07-31 | 2,169,585 | +13.1% | 7.36 | 294,587 |
| 2026-07-15 | 1,918,207 | -9.6% | 4.99 | 384,586 |
| 2026-06-30 | 2,121,617 | +25.6% | 2.60 | 814,837 |
| 2026-06-15 | 1,689,714 | +3.1% | 8.33 | 202,905 |
| 2026-05-29 | 1,638,411 | +8.8% | 8.18 | 200,370 |
| 2026-05-15 | 1,505,179 | +3.4% | 6.67 | 225,682 |
| 2026-04-30 | 1,455,087 | +3.4% | 7.97 | 182,483 |
| 2026-04-15 | 1,406,701 | -5.9% | 5.26 | 267,195 |
| 2026-03-31 | 1,495,607 | +2.5% | 6.45 | 232,042 |
| 2026-03-13 | 1,458,857 | +5.8% | 5.76 | 253,255 |
| 2026-02-27 | 1,378,177 | +0.5% | 9.02 | 152,774 |
| 2026-02-13 | 1,371,498 | +6.9% | 6.93 | 197,947 |
| 2026-01-30 | 1,283,046 | +1.2% | 6.49 | 197,719 |
| 2026-01-15 | 1,267,548 | +1.7% | 4.55 | 278,570 |
| 2025-12-31 | 1,246,230 | +13.7% | 6.81 | 183,019 |
| 2025-12-15 | 1,095,980 | -1.1% | 4.77 | 229,579 |
| 2025-11-28 | 1,108,765 | +5.6% | 4.81 | 230,731 |
| 2025-11-14 | 1,050,284 | -5.2% | 4.24 | 247,959 |
| 2025-10-31 | 1,107,928 | -6.2% | 7.24 | 153,114 |
| 2025-10-15 | 1,180,914 | -1.2% | 9.37 | 126,096 |
| 2025-09-30 | 1,195,235 | +6.5% | 4.58 | 260,967 |
import finzdata as yf
yf.Ticker("LGND").short_interest # every report since 2017
yf.Client().short_interest(["LGND"], start="2018-01-01")Healthcare short interest · LGND price history · Who owns LGND · All short interest